Key result
Central chemosensitivity plays a role in the pathophysiology of central apnea in patients with heart failure.
Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Should not yet change management of central apnea in HF; hypothesis-generating for chemosensitivity-targeted therapies.
Wilcox et al. (1993) studied this question. Central chemosensitivity plays a role in the pathophysiology of central apnea in patients with heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: